Hot Features
プレミアム
enGene Therapeutics Inc (ENGN)
NASDAQ
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-01-30 | Dr. Anthony T. CheungCo-Founder & Chief Scientific Officer | 195.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | 7.03 | 977.57k | 24.92% |
| 2026-01-30 | Ms. Joan ConnollyCTO | 195.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | 7.03 | 405.00k | 92.86% |
| 2026-01-30 | Ms. Jill BuckChief Development Officer | 195.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | 7.03 | 414.00k | 89.04% |
| 2026-01-30 | Mr. Ronald H. W. CooperPresident, CEO & Director | 801.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | 7.03 | 2.90M | 38.14% |
| 2026-01-30 | Mr. Matthew BoydChief Regulatory Officer | 195.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | 7.03 | 414.00k | 89.04% |
| 2025-09-30 | Dr. Hussein Sweitiインサイダー | 600.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 600.00k | - |
| 2025-07-08 | Mr. Philip Astley-SparkeIndependent Non-Executive Director | 45.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 45.00k | - |
| 2025-07-08 | Ms. Jill BuckChief Development Officer | 100.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 219.00k | 84.03% |
| 2025-07-08 | Mr. Matthew BoydChief Regulatory Officer | 100.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 219.00k | 84.03% |
| 2025-07-08 | Mr. Michael Thomas HeffernanIndependent Non-Executive Director | 45.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 45.00k | - |
| 2025-07-08 | Dr. William J. GrossmanInterim Chief Medical Officer & Director | 45.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 45.00k | - |
| 2025-07-08 | Ms. Jill BuckChief Development Officer | 119.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 119.00k | - |
| 2025-07-08 | Mr. Matthew BoydChief Regulatory Officer | 119.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 119.00k | - |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
